Associate Professor Patricia J. Zettler, a former official with the Food and Drug Administration and a Second Century Initiative faculty member in the College of Law’s Center for Law, Health & Society recently spoke with WSB-TV (Channel 2) in Atlanta about FDA oversight of stem cell interventions.
Click here to read the story and view the WSB-TV segment. Professor Zettler’s interview appears at 2:12 in the video.
From the story:
Former Food and Drug Administration attorney Patti Zettler said there has been some debate over the policing of stem cell interventions. She said since 2017 the FDA increased its oversight over stem cells and gave doctors offering stem cell treatments three years to provide clinical proof their treatments are safe and effective. FDA has the authority to take immediate action if a patient’s safety is at risk.
Zettler cautioned the late enforcement may create challenges for federal regulators. “Once products are out there, once interventions are out there being provided to patents it is more difficult to rein in the business to rein in that practice,” she said.
Learn more about the professor by reading a 2CI Faculty Q&A here on the Next Generation Program website.
– Jeremy Craig, PR Manager for Strategic Initiatives & Innovation, Office of the Provost